ORGANIC
LETTERS
2011
Vol. 13, No. 4
696–699
Total Synthesis of (-)-Brevisin:
A Concise Synthesis of a New Marine
Polycyclic Ether
Takefumi Kuranaga,† Naohito Ohtani,† Ryosuke Tsutsumi,† Daniel G. Baden,‡
Jeffrey L. C. Wright,‡ Masayuki Satake,*,† and Kazuo Tachibana*,†
Department of Chemistry, School of Science, The University of Tokyo, 7-3-1 Hongo,
Bunkyo-ku, Tokyo 113-0033, Japan, and Center for Marine Science,
University of North Carolina;Wilmington, 5600 Marvin K. Moss Lane,
Wilmington, North Carolina 28409, United States
msatake@chem.s.u-tokyo.ac.jp; ktachi@chem.s.u-tokyo.ac.jp
Received December 2, 2010
ABSTRACT
The first and highly efficient total synthesis of (-)-brevisin has been achieved. The title compound was synthesized in only 29 steps (longest linear
sequence) from commercially available starting materials. The synthesis provided over 70 mg of a marine polycyclic ether compound.
The polycyclic ether (-)-brevisin1 (1, Figure 1) was
isolated from the red tide dinoflagellate Karenia brevis,
which produces a variety of polycyclic ethers such as the
brevetoxins,2 brevenal,3 and the monocyclic ether amide
brevisamide.4 Brevisin’s unique structure consists of two
fused tricyclic ether ring assemblies bridged by a methylene
carbon and a conjugated aldehyde side chain, which is
similar to the side chain in brevenal and bevisamide.
Interestingly, despite 1 having a unique structure, which is
divided into two tricyclic ether units by the methylene, 1
inhibits the binding of tritiated 42-dihydrobrevetoxin B
(PbTx-3) to the voltage sensitive sodium channels.1a How-
ever, as with the other marine polycyclic ethers, the
biological activities of 1 have not been fully investigated
due to the extremely small supply from natural sources.
In order to elucidate its interaction with a target protein
and test other biological activities, such as mouse
lethality and cytotoxicity, the chemical synthesis for
† The University of Tokyo.
‡ University of North Carolina;Wilmington.
(1) (a) Satake, M.; Campbell, A.; Van Wagoner, R. M.; Bourdelais,
A. J.; Jacocks, H.; Baden, D. G.; Wright, J. L. C. J. Org. Chem. 2009, 74,
989. (b) Van Wagoner, R. M.; Satake, M.; Bourdelais, A. J.; Baden,
D. G.; Wright, J. L. C. J. Nat. Prod. 2010, 73, 1177. (c) Kuranaga, T.;
Satake, M.; Baden, D. G.; Wright, J. L. C.; Tachibana, K. Tetrahedron
Lett. 2010, 51, 4673.
(2) (a) Lin, Y.-Y.; Risk, M.; Ray, S. M.; Van Engen, D.; Clardy, J.;
Golik, J.; James, J. C.; Nakanishi, K. J. Am. Chem. Soc. 1981, 103, 6773.
(b) Shimizu, Y.; Chou, H. N.; Bando, H.; Van Duyne, G.; Clardy, J.
J. Am. Chem. Soc. 1986, 108, 514. (c) Baden, D. G.; Bourdelais, A. J.;
Jacocks, H.; Michelliza, S.; Naar, J. J. Environ. Health Perspect. 2005,
113, 621.
(4) (a) Satake, M.; Bourdelais, A. J.; Van Wagoner, R. M.; Baden,
D. G.; Wright, J. L. C. Org. Lett. 2008, 10, 3465. We have successfuly
synthesized brevisamide and tested its biological activities:(b) Kuranaga,
T.; Shirai, T.; Baden, D. G.; Wright, J. L. C.; Satake, M.; Tachibana, K.
Org. Lett. 2009, 11, 217. (c) Tsutsumi, R.; Kuranaga, T.; Wright, J. L. C.;
Baden, D. G.; Ito, E.; Satake, M.; Tachibana, K. Tetrahedron 2010, 66,
6775.
(3) (a) Bourdelais, A. J.; Jacocks, H. M.; Wright, J. L. C.; Bigwarfe,
P. M., Jr; Baden, D. G. J. Nat. Prod. 2005, 68, 2. (b) The proposed
structure was revised: Fuwa, H.; Ebine, M.; Bourdelais, A. J.; Baden,
D. G.; Sasaki, M. J. Am. Chem. Soc. 2006, 128, 16989.
r
10.1021/ol102925d
Published on Web 01/19/2011
2011 American Chemical Society